MAIA Biotechnology
Stuart Byham has over 13 years of experience in clinical research and project management. In 2021, they joined MAIA Biotechnology, Inc. as the Sr. Director of Clinical Development and Operations. Prior to that, they served as a Contract Copywriter for Media Partners, Inc. in 2012 and a Clinical Research Consultant from 2019 to 2021. From 2010 to 2012, they were a Board Member for Raleigh Little Theatre. From 2018 to 2019, they were the Director of Clinical Trials at CTI Clinical Trial and Consulting Services. From 2014 to 2018, they were a Sr. Project Manager at MedSource and a Project Director at Aerotek in 2012. From 2011 to 2014, they were a Sr. Project Manager at Camargo Pharmaceutical Services. From 2009 to 2011, they were an Associate Director of Project Management and Sr. Global Project Manager at i3 Research. From 2008 to 2009, they were an Associate Director of Cardiovascular & Critical Care at PPD, Inc.
Stuart Byham received their Masters from The University of Alabama, their BA from the University of West Florida, and graduated from Carmi High School.
This person is not in any offices
MAIA Biotechnology
2 followers
MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.